Ocrevus 300 MG/10 ML vial 10ML

Ended Awarded

Contract number
SPE2DB25FWXJN
Awardee
Awarding agency
Obligated
$84,135

Award facts

Contract value 100% obligated
$84,134.96 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

This is a $84,134.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 300 mg/10 mL vials of the drug OCREVUS over a period ending on June 5, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global pharmaceutical support through December 2026. The contract is not set aside for any specific business type.

Quick answers

Who was awarded contract SPE2DB25FWXJN?

SPE2DB25FWXJN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 14, 2025.

How much is contract SPE2DB25FWXJN worth?

The government has obligated $84,135 on SPE2DB25FWXJN.

Is contract SPE2DB25FWXJN an order under another contract?

Yes. SPE2DB25FWXJN is a delivery order under SPE2DB25D3012, an indefinite delivery contract.

Was contract SPE2DB25FWXJN competed?

The extent of competition for SPE2DB25FWXJN was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login